Lipitor Topped Worldwide Drug Sales in 2010; Crestor Gains Most
The following table ranks the top 15 prescription drugs sold by pharmaceutical and biotechnology companies in 2010 and shows year-over-year sales comparisons. The rankings are based on data from company figures. Sales of drugs sold by multiple companies are combined. All figures are in U.S. dollars. Foreign currency exchange rates were based on the average annual swap price.
Drug Name Used For Company 2010 SALES Y-O-Y Rank
(BLN US$) Change ================================================================ 1. Lipitor High Pfizer 10.7 -6%
cholesterol
2. Plavix Blood clot Bristol-Myers/ 9.43 -4%
prevention Sanofi-Aventis
3. Remicade Rheumatoid J&J/Merck & Co./ 7.99 N/A
arthritis/ Mitsubishi Tanabe
Psoriasis/
Crohn’s disease 4. Advair/ Asthma GlaxoSmithKline 7.94 2%
Seretide
5. Enbrel Rheumatoid Amgen/Pfizer 7.23 N/A
arthritis/ Takeda
Psoriasis
6. Abilify Depression/ Otsuka/ 6.78* N/A
Bipolar Bristol-Myers
disorder/
Schizophrenia
7. Humira Rheumatoid Abbott 6.55 19%
arthritis/
Psoriasis/
Crohn’s disease
8. Avastin Cancer Roche 6.22 8%
9. Rituxan/ Lymphoma/ Roche/Biogen Idec 6.11 9%
Mabthera Leukemia
10. Diovan High blood Novartis 6.05 1%
pressure
11. Crestor High AstraZeneca 5.69 26%
cholesterol
12. Seroquel Depression/ AstraZeneca 5.3 9%
Bipolar
disorder/
Schizophrenia
13. Herceptin Breast Roche 5.22 7%
cancer
14. Zyprexa Bipolar Eli Lilly 5.03 2%
disorder/
Schizophrenia
15. Singulair Asthma/ Merck & Co. 4.99 7%
Allergies
*Estimated, Otsuka declined to provide 2010 sales. Some year- over-year sales comparisons are N/A because there isn’t comparable 2009 data.
To contact the reporter on this story: Catherine Larkin in Washington at clarkin4@bloomberg.net.
To contact the editor responsible for this story: Reg Gale at rgale5@bloomberg.net.
Rate this Page